Breaking News

CEPI and Intravacc Partner to Develop Betacoronavirus Vaccine

CEPI will provide seed funding of up to $4.8 million to Intravacc to advance R&D of preventative therapeutic vaccines.

Author Image

By: Charlie Sternberg

Associate Editor

CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc, have announced the latest funding award under CEPI’s $200 million program to advance the development of vaccines that provide broad protection against SARS-CoV-2 (including its variants) and other Betacoronaviruses.   CEPI will provide seed funding of up to $4.8 million to Intravacc—a world leader in translational research and development of preventive and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters